Evidence map›Paper›PMID 28765281›Full record

ArticleThe Journal of biological chemistry2017

p38 MAPK inhibits nonsense-mediated RNA decay in response to persistent DNA damage in noncycling cells.

Andrew Nickless, Abigael Cheruiyot, Kevin C Flanagan, David Piwnica-Worms, Sheila A Stewart, Zhongsheng You

Open access · hybridAbstract readComparative Study
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Andrew NicklessFrom the Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri 63110 and.
Abigael CheruiyotFrom the Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri 63110 and.
Kevin C FlanaganFrom the Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri 63110 and.
David Piwnica-Wormsthe Department of Cancer Systems Imaging, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030.
Sheila A StewartFrom the Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri 63110 and.
Zhongsheng YouFrom the Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri 63110 and zyou@wustl.edu.
Washington University in St. Louis · USThe University of Texas MD Anderson Cancer Center · US

Funding

MOLECULAR MECHANISMS OF DNA DAMAGE SIGNALING AND REPAIRR01GM098535 · NIGMS · WASHINGTON UNIVERSITY · PI PISTON, DAVID W · 2012 to 2025
$4.2M
Howard Hughes Medical InstituteNIGMS NIH HHS R01 GM098535
6 · The paper itself

Abstract

Persistent DNA damage induces profound alterations in gene expression that, in turn, influence tissue homeostasis, tumorigenesis, and cancer treatment outcome. However, the underlying mechanism for gene expression reprogramming induced by persistent DNA damage remains poorly understood. Here, using a highly effective bioluminescence-based reporter system and other tools, we report that persistent DNA damage inhibits nonsense-mediated RNA decay (NMD), an RNA surveillance and gene-regulatory pathway, in noncycling cells. NMD suppression by persistent DNA damage required the activity of the p38α MAPK. Activating transcription factor 3 (ATF3), an NMD target and a key stress-inducible transcription factor, was stabilized in a p38α- and NMD-dependent manner following persistent DNA damage. Our results reveal a novel p38α-dependent pathway that regulates NMD activity in response to persistent DNA damage, which, in turn, controls ATF3 expression in affected cells.

Indexed as

DNA DamageGene Expression RegulationNonsense Mediated mRNA DecayActivating Transcription Factor 3BiomarkersBleomycinCells, CulturedCellular SenescenceEnzyme ActivationGamma RaysGenes, ReporterHEK293 CellsHumansLuminescent MeasurementsMitogen-Activated Protein Kinase 14MutagensActivating Transcription Factor 3ATF3 protein, humanBiomarkersBleomycinMitogen-Activated Protein Kinase 14MutagensRNA, MessengerATF3DNA damage responsegene expressionmRNA decaynonsense-mediated RNA decayp38persistent DNA damagesenescence

Identifiers

PMID28765281
PMCPMC5602387
OpenAlexW2741472746

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.